Skip to content

Clinical trials

Hemolysis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemolysis Country / region: China Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20171
20201
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status5
Completed1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CARE Pharma Shanghai Ltd.1
China National Biotec Group Company Limited1
First Affiliated Hospital, Sun Yat-Sen University1
Institute of Hematology & Blood Diseases Hospital, China1
Qianfoshan Hospital1
Sun Yat-sen University1
The First Affiliated Hospital with Nanjing Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemolysis7
Anemia1
Anemia, Hemolytic1
Anemia, Hemolytic, Autoimmune1
Autoimmune Diseases1
COVID-191
Coronary Artery Disease1
Glucosephosphate Dehydrogenase Deficiency1
Hematologic Diseases1
Hyperkalemia1

Trials

Showing 51 to 7 of 7. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.